Trial Profile
Pharmacokinetics of tivantinib +/- ketoconazole in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Apr 2012
Price :
$35
*
At a glance
- Drugs Tivantinib (Primary) ; Ketoconazole
- Indications Colorectal cancer; Gastric cancer; Germ cell cancer; Liver cancer; Non-small cell lung cancer; Pancreatic cancer; Renal cancer; Soft tissue sarcoma
- Focus Pharmacokinetics
- Sponsors ArQule; Daiichi Sankyo Company
- 02 Apr 2012 New trial record